Pharma & Healthcare

Global Management of Antithrombin Market Research Report 2026

This report delivers a comprehensive overview of the global Management of Antithrombin market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Management of Antithrombin. The Management of Antithrombin market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Management of Antithrombin market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Management of Antithrombin manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Grifols
rEVO Biologics Inc.
Takeda
Kedrion S.p.A.
CSL Limited
Scripps Laboratories Inc.
Lee Biosolutions
Segment by Type
Liquid
Lyophilized
Segment by Application
Diagnostics
Therapeutics
Research
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Rest of Asia
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Rest of MEA
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Management of Antithrombin companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Management of Antithrombin Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Liquid
1.2.3 Lyophilized
1.3 Market by Application
1.3.1 Global Management of Antithrombin Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Diagnostics
1.3.3 Therapeutics
1.3.4 Research
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Management of Antithrombin Market Perspective (2021–2032)
2.2 Global Management of Antithrombin Growth Trends by Region
2.2.1 Global Management of Antithrombin Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Management of Antithrombin Historic Market Size by Region (2021–2026)
2.2.3 Management of Antithrombin Forecasted Market Size by Region (2027–2032)
2.3 Management of Antithrombin Market Dynamics
2.3.1 Management of Antithrombin Industry Trends
2.3.2 Management of Antithrombin Market Drivers
2.3.3 Management of Antithrombin Market Challenges
2.3.4 Management of Antithrombin Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Management of Antithrombin Players by Revenue
3.1.1 Global Top Management of Antithrombin Players by Revenue (2021–2026)
3.1.2 Global Management of Antithrombin Revenue Market Share by Players (2021–2026)
3.2 Global Top Management of Antithrombin Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Management of Antithrombin Revenue
3.4 Global Management of Antithrombin Market Concentration Ratio
3.4.1 Global Management of Antithrombin Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Management of Antithrombin Revenue in 2025
3.5 Global Key Players of Management of Antithrombin Head Offices and Areas Served
3.6 Global Key Players of Management of Antithrombin, Products and Applications
3.7 Global Key Players of Management of Antithrombin, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Management of Antithrombin Breakdown Data by Type
4.1 Global Management of Antithrombin Historic Market Size by Type (2021–2026)
4.2 Global Management of Antithrombin Forecasted Market Size by Type (2027–2032)
5 Management of Antithrombin Breakdown Data by Application
5.1 Global Management of Antithrombin Historic Market Size by Application (2021–2026)
5.2 Global Management of Antithrombin Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Management of Antithrombin Market Size (2021–2032)
6.2 North America Management of Antithrombin Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Management of Antithrombin Market Size by Country (2021–2026)
6.4 North America Management of Antithrombin Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Management of Antithrombin Market Size (2021–2032)
7.2 Europe Management of Antithrombin Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Management of Antithrombin Market Size by Country (2021–2026)
7.4 Europe Management of Antithrombin Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Management of Antithrombin Market Size (2021–2032)
8.2 Asia-Pacific Management of Antithrombin Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Management of Antithrombin Market Size by Region (2021–2026)
8.4 Asia-Pacific Management of Antithrombin Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Management of Antithrombin Market Size (2021–2032)
9.2 Latin America Management of Antithrombin Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Management of Antithrombin Market Size by Country (2021–2026)
9.4 Latin America Management of Antithrombin Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Management of Antithrombin Market Size (2021–2032)
10.2 Middle East & Africa Management of Antithrombin Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Management of Antithrombin Market Size by Country (2021–2026)
10.4 Middle East & Africa Management of Antithrombin Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Grifols
11.1.1 Grifols Company Details
11.1.2 Grifols Business Overview
11.1.3 Grifols Management of Antithrombin Introduction
11.1.4 Grifols Revenue in Management of Antithrombin Business (2021–2026)
11.1.5 Grifols Recent Development
11.2 rEVO Biologics Inc.
11.2.1 rEVO Biologics Inc. Company Details
11.2.2 rEVO Biologics Inc. Business Overview
11.2.3 rEVO Biologics Inc. Management of Antithrombin Introduction
11.2.4 rEVO Biologics Inc. Revenue in Management of Antithrombin Business (2021–2026)
11.2.5 rEVO Biologics Inc. Recent Development
11.3 Takeda
11.3.1 Takeda Company Details
11.3.2 Takeda Business Overview
11.3.3 Takeda Management of Antithrombin Introduction
11.3.4 Takeda Revenue in Management of Antithrombin Business (2021–2026)
11.3.5 Takeda Recent Development
11.4 Kedrion S.p.A.
11.4.1 Kedrion S.p.A. Company Details
11.4.2 Kedrion S.p.A. Business Overview
11.4.3 Kedrion S.p.A. Management of Antithrombin Introduction
11.4.4 Kedrion S.p.A. Revenue in Management of Antithrombin Business (2021–2026)
11.4.5 Kedrion S.p.A. Recent Development
11.5 CSL Limited
11.5.1 CSL Limited Company Details
11.5.2 CSL Limited Business Overview
11.5.3 CSL Limited Management of Antithrombin Introduction
11.5.4 CSL Limited Revenue in Management of Antithrombin Business (2021–2026)
11.5.5 CSL Limited Recent Development
11.6 Scripps Laboratories Inc.
11.6.1 Scripps Laboratories Inc. Company Details
11.6.2 Scripps Laboratories Inc. Business Overview
11.6.3 Scripps Laboratories Inc. Management of Antithrombin Introduction
11.6.4 Scripps Laboratories Inc. Revenue in Management of Antithrombin Business (2021–2026)
11.6.5 Scripps Laboratories Inc. Recent Development
11.7 Lee Biosolutions
11.7.1 Lee Biosolutions Company Details
11.7.2 Lee Biosolutions Business Overview
11.7.3 Lee Biosolutions Management of Antithrombin Introduction
11.7.4 Lee Biosolutions Revenue in Management of Antithrombin Business (2021–2026)
11.7.5 Lee Biosolutions Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Management of Antithrombin Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of Liquid
Table 3. Key Players of Lyophilized
Table 4. Global Management of Antithrombin Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 5. Global Management of Antithrombin Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 6. Global Management of Antithrombin Market Size by Region (US$ Million), 2021–2026
Table 7. Global Management of Antithrombin Market Share by Region (2021–2026)
Table 8. Global Management of Antithrombin Forecasted Market Size by Region (US$ Million), 2027–2032
Table 9. Global Management of Antithrombin Market Share by Region (2027–2032)
Table 10. Management of Antithrombin Market Trends
Table 11. Management of Antithrombin Market Drivers
Table 12. Management of Antithrombin Market Challenges
Table 13. Management of Antithrombin Market Restraints
Table 14. Global Management of Antithrombin Revenue by Players (US$ Million), 2021–2026
Table 15. Global Management of Antithrombin Market Share by Players (2021–2026)
Table 16. Global Top Management of Antithrombin Players by Tier (Tier 1, Tier 2, and Tier 3), based on Management of Antithrombin Revenue, 2025
Table 17. Ranking of Global Top Management of Antithrombin Companies by Revenue (US$ Million) in 2025
Table 18. Global 5 Largest Players Market Share by Management of Antithrombin Revenue (CR5 and HHI), 2021–2026
Table 19. Global Key Players of Management of Antithrombin, Headquarters and Area Served
Table 20. Global Key Players of Management of Antithrombin, Products and Applications
Table 21. Global Key Players of Management of Antithrombin, Date of General Availability (GA)
Table 22. Mergers and Acquisitions, Expansion Plans
Table 23. Global Management of Antithrombin Market Size by Type (US$ Million), 2021–2026
Table 24. Global Management of Antithrombin Revenue Market Share by Type (2021–2026)
Table 25. Global Management of Antithrombin Forecasted Market Size by Type (US$ Million), 2027–2032
Table 26. Global Management of Antithrombin Revenue Market Share by Type (2027–2032)
Table 27. Global Management of Antithrombin Market Size by Application (US$ Million), 2021–2026
Table 28. Global Management of Antithrombin Revenue Market Share by Application (2021–2026)
Table 29. Global Management of Antithrombin Forecasted Market Size by Application (US$ Million), 2027–2032
Table 30. Global Management of Antithrombin Revenue Market Share by Application (2027–2032)
Table 31. North America Management of Antithrombin Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 32. North America Management of Antithrombin Market Size by Country (US$ Million), 2021–2026
Table 33. North America Management of Antithrombin Market Size by Country (US$ Million), 2027–2032
Table 34. Europe Management of Antithrombin Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 35. Europe Management of Antithrombin Market Size by Country (US$ Million), 2021–2026
Table 36. Europe Management of Antithrombin Market Size by Country (US$ Million), 2027–2032
Table 37. Asia-Pacific Management of Antithrombin Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 38. Asia-Pacific Management of Antithrombin Market Size by Region (US$ Million), 2021–2026
Table 39. Asia-Pacific Management of Antithrombin Market Size by Region (US$ Million), 2027–2032
Table 40. Latin America Management of Antithrombin Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 41. Latin America Management of Antithrombin Market Size by Country (US$ Million), 2021–2026
Table 42. Latin America Management of Antithrombin Market Size by Country (US$ Million), 2027–2032
Table 43. Middle East & Africa Management of Antithrombin Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 44. Middle East & Africa Management of Antithrombin Market Size by Country (US$ Million), 2021–2026
Table 45. Middle East & Africa Management of Antithrombin Market Size by Country (US$ Million), 2027–2032
Table 46. Grifols Company Details
Table 47. Grifols Business Overview
Table 48. Grifols Management of Antithrombin Product
Table 49. Grifols Revenue in Management of Antithrombin Business (US$ Million), 2021–2026
Table 50. Grifols Recent Development
Table 51. rEVO Biologics Inc. Company Details
Table 52. rEVO Biologics Inc. Business Overview
Table 53. rEVO Biologics Inc. Management of Antithrombin Product
Table 54. rEVO Biologics Inc. Revenue in Management of Antithrombin Business (US$ Million), 2021–2026
Table 55. rEVO Biologics Inc. Recent Development
Table 56. Takeda Company Details
Table 57. Takeda Business Overview
Table 58. Takeda Management of Antithrombin Product
Table 59. Takeda Revenue in Management of Antithrombin Business (US$ Million), 2021–2026
Table 60. Takeda Recent Development
Table 61. Kedrion S.p.A. Company Details
Table 62. Kedrion S.p.A. Business Overview
Table 63. Kedrion S.p.A. Management of Antithrombin Product
Table 64. Kedrion S.p.A. Revenue in Management of Antithrombin Business (US$ Million), 2021–2026
Table 65. Kedrion S.p.A. Recent Development
Table 66. CSL Limited Company Details
Table 67. CSL Limited Business Overview
Table 68. CSL Limited Management of Antithrombin Product
Table 69. CSL Limited Revenue in Management of Antithrombin Business (US$ Million), 2021–2026
Table 70. CSL Limited Recent Development
Table 71. Scripps Laboratories Inc. Company Details
Table 72. Scripps Laboratories Inc. Business Overview
Table 73. Scripps Laboratories Inc. Management of Antithrombin Product
Table 74. Scripps Laboratories Inc. Revenue in Management of Antithrombin Business (US$ Million), 2021–2026
Table 75. Scripps Laboratories Inc. Recent Development
Table 76. Lee Biosolutions Company Details
Table 77. Lee Biosolutions Business Overview
Table 78. Lee Biosolutions Management of Antithrombin Product
Table 79. Lee Biosolutions Revenue in Management of Antithrombin Business (US$ Million), 2021–2026
Table 80. Lee Biosolutions Recent Development
Table 81. Research Programs/Design for This Report
Table 82. Key Data Information from Secondary Sources
Table 83. Key Data Information from Primary Sources
Table 84. Authors List of This Report


List of Figures
Figure 1. Management of Antithrombin Picture
Figure 2. Global Management of Antithrombin Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global Management of Antithrombin Market Share by Type: 2025 vs 2032
Figure 4. Liquid Features
Figure 5. Lyophilized Features
Figure 6. Global Management of Antithrombin Market Size by Application (US$ Million), 2021–2032
Figure 7. Global Management of Antithrombin Market Share by Application: 2025 vs 2032
Figure 8. Diagnostics Case Studies
Figure 9. Therapeutics Case Studies
Figure 10. Research Case Studies
Figure 11. Management of Antithrombin Report Years Considered
Figure 12. Global Management of Antithrombin Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 13. Global Management of Antithrombin Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 14. Global Management of Antithrombin Market Share by Region: 2025 vs 2032
Figure 15. Global Management of Antithrombin Market Share by Players in 2025
Figure 16. Global Management of Antithrombin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 17. The Top 10 and 5 Players Market Share by Management of Antithrombin Revenue in 2025
Figure 18. North America Management of Antithrombin Market Size YoY Growth (US$ Million), 2021–2032
Figure 19. North America Management of Antithrombin Market Share by Country (2021–2032)
Figure 20. United States Management of Antithrombin Market Size YoY Growth (US$ Million), 2021–2032
Figure 21. Canada Management of Antithrombin Market Size YoY Growth (US$ Million), 2021–2032
Figure 22. Europe Management of Antithrombin Market Size YoY Growth (US$ Million), 2021–2032
Figure 23. Europe Management of Antithrombin Market Share by Country (2021–2032)
Figure 24. Germany Management of Antithrombin Market Size YoY Growth (US$ Million), 2021–2032
Figure 25. France Management of Antithrombin Market Size YoY Growth (US$ Million), 2021–2032
Figure 26. U.K. Management of Antithrombin Market Size YoY Growth (US$ Million), 2021–2032
Figure 27. Italy Management of Antithrombin Market Size YoY Growth (US$ Million), 2021–2032
Figure 28. Russia Management of Antithrombin Market Size YoY Growth (US$ Million), 2021–2032
Figure 29. Ireland Management of Antithrombin Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. Asia-Pacific Management of Antithrombin Market Size YoY Growth (US$ Million), 2021–2032
Figure 31. Asia-Pacific Management of Antithrombin Market Share by Region (2021–2032)
Figure 32. China Management of Antithrombin Market Size YoY Growth (US$ Million), 2021–2032
Figure 33. Japan Management of Antithrombin Market Size YoY Growth (US$ Million), 2021–2032
Figure 34. South Korea Management of Antithrombin Market Size YoY Growth (US$ Million), 2021–2032
Figure 35. Southeast Asia Management of Antithrombin Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. India Management of Antithrombin Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. Australia & New Zealand Management of Antithrombin Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. Latin America Management of Antithrombin Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. Latin America Management of Antithrombin Market Share by Country (2021–2032)
Figure 40. Mexico Management of Antithrombin Market Size YoY Growth (US$ Million), 2021–2032
Figure 41. Brazil Management of Antithrombin Market Size YoY Growth (US$ Million), 2021–2032
Figure 42. Middle East & Africa Management of Antithrombin Market Size YoY Growth (US$ Million), 2021–2032
Figure 43. Middle East & Africa Management of Antithrombin Market Share by Country (2021–2032)
Figure 44. Israel Management of Antithrombin Market Size YoY Growth (US$ Million), 2021–2032
Figure 45. Saudi Arabia Management of Antithrombin Market Size YoY Growth (US$ Million), 2021–2032
Figure 46. UAE Management of Antithrombin Market Size YoY Growth (US$ Million), 2021–2032
Figure 47. Grifols Revenue Growth Rate in Management of Antithrombin Business (2021–2026)
Figure 48. rEVO Biologics Inc. Revenue Growth Rate in Management of Antithrombin Business (2021–2026)
Figure 49. Takeda Revenue Growth Rate in Management of Antithrombin Business (2021–2026)
Figure 50. Kedrion S.p.A. Revenue Growth Rate in Management of Antithrombin Business (2021–2026)
Figure 51. CSL Limited Revenue Growth Rate in Management of Antithrombin Business (2021–2026)
Figure 52. Scripps Laboratories Inc. Revenue Growth Rate in Management of Antithrombin Business (2021–2026)
Figure 53. Lee Biosolutions Revenue Growth Rate in Management of Antithrombin Business (2021–2026)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies